Baxter Shares Tank As 2026 Profit Guidance Falls Below Expectations

Baxter reported a fourth-quarter adjusted EPS of 44 cents, below the management guidance of 52-57 cents and the Wall Street estimate of 54 cents. The decrease was driven primarily by an unfavorable product mix.The medical device maker reported sales of $2.974 billion, up 8% year over year on a reported basis and 3% on an operational basis, beating the consensus of $2.824 billion.Management expected fourth-quarter sales growth of approximately 2% on a reported basis and a decline of approximately 2% on an op ...